Summary:
Endovasc’s licenses and patents describe technological advancements related to liposomes, stent coatings, and biodegradable/resorbable prostheses (stents) for the treatment of vascular dysfunction and heart disease. It also holds licenses and patents for the treatment of vascular dysfunction related to heart disease.
Visit ENDOVASC Inc..

Description (Web site quote):
Pending completion of FDA clinical trials, these products and technologies have the potential to:

* Dramatically improve patient quality of life.
* Reduce the need for costly repeat procedures for cardiac patients.
* Reduce healthcare costs.
* Introduce new paradigms of medical treatment by using the patient’s own stem cells.
Visit ENDOVASC Inc..